Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Circular Genomics logo — company profile

Circular Genomics

Founded 2021 United States Albuquerque, United States 15 employees Series A Total: $12.83M Biotechnology, Health Care +1

General Information

Company Name Circular Genomics
Founded Year 2021
Location United States Albuquerque, United States
Employees 15
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Circular Genomics. To contact Circular Genomics, visit circulargenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Circular Genomics compare?

A PDF of Circular Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Circular Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Circular Genomics

Circular Genomics is a biotechnology startup founded in 2021 and headquartered in the United States. The company is focused on utilizing circular RNA as a novel biomarker to drive precision medicine for the enhancement of diagnosis and treatment of neurological and psychiatric conditions.

The startup recently secured a notable $8.30M Series A investment on 23 January 2024. The investment was backed by prominent firms including Mountain Group Partners, Cottonwood Technology Fund, Tramway Ventures, and UNM Rainforest Innovations.

Circular Genomics' innovative approach to leveraging circular RNA for precision medicine in the biotechnology and healthcare industries makes it a compelling prospect for venture capital investors seeking opportunities in disruptive healthcare technologies.

Business keywords: Circular Genomics, neurological conditions, psychiatric conditions, precision medicine, biomarker, circular RNA, diagnosis, treatment, Albuquerque, New Mexico

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $8.30M 4
Cottonwood Technology Fund UNM Rainforest Innovations
Cottonwood Technology Fund, UNM Rainforest Innovations +2
23 Jan 2024
Grant $25.00K 1
New Mexico Economic Development Department
24 Jan 2023
Seed Round $4.50M 3
Cottonwood Technology Fund
Cottonwood Technology Fund, Mountain Group Capital +1
14 Dec 2021

Circular Genomics Alternatives & Competitors

View All Alternatives
Circular Genomics vs
Rgenta Therapeutics Inc.
Rgenta Therapeutics Inc. United States

We unlock the therapeutic potentials of highly disease-relevant targets undruggable by small molecul...

Series A
31 employees
Biotechnology, Health Care
Circular Genomics vs
OncXerna Therapeutics
OncXerna Therapeutics United States

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel,...

Venture round
8 employees
Biopharma, Biotechnology
Circular Genomics vs
Tute Genomics
Tute Genomics United States

Tute Genomics is a Utah-based company that is powering the world's genomic knowledge with a cloud-ba...

Series A
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About Circular Genomics

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions
Circular Genomics was founded in 2021.
Circular Genomics is headquartered in Albuquerque, United States.
Circular Genomics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Circular Genomics, neurological conditions, psychiatric conditions and precision medicine.
Circular Genomics has approximately 15 employees.
Circular Genomics has completed 3 funding rounds, raising a total of $12.83M. The latest funding stage is Series A.
Top alternatives and competitors to Circular Genomics include Rgenta Therapeutics Inc., OncXerna Therapeutics , Tute Genomics, Biofidelity, Ascidian Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Circular Genomics and Rgenta Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Circular Genomics, https://bouncewatch.com/company/circular-genomics, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes